6-136278253-C-T
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_014739.3(BCLAF1):c.628G>A(p.Gly210Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000163 in 1,603,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_014739.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000976 AC: 146AN: 149540Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0104 AC: 2550AN: 246102 AF XY: 0.0103 show subpopulations
GnomAD4 exome AF: 0.0000798 AC: 116AN: 1453836Hom.: 0 Cov.: 32 AF XY: 0.0000719 AC XY: 52AN XY: 723224 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.000976 AC: 146AN: 149658Hom.: 0 Cov.: 32 AF XY: 0.00115 AC XY: 84AN XY: 73152 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - 5% MAF in Finnish population. Both parents carry this variant in the heterozygous state - variants in this gene are unlikely to be related to patient phenotype. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at